Penicillamine-induced type II bullous systemic lupus erythematosus.
Condon
C
C
Phelan
M
M
Lyons
J F
JF
D000328:Adult; D018501:Antirheumatic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced*; D010396:Penicillamine / Q000009:adverse effects*; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced*
D018501:Antirheumatic Agents; D010396:Penicillamine